Aktien Sensor

Alcon AG’s disappointing Q2 earnings, marked by 4% revenue growth and missed profitability targets, has led to a rewriting of annual targets and a decline in stock price.

Straumann Holding AG’s stock price has been volatile due to broader market trends and medical technology sector news, but the company’s strong fundamentals suggest long-term potential.

Siemens Healthineers AG’s stock price decline is a buying opportunity for investors, driven by the company’s long-term prospects in the medical imaging and laboratory diagnostics space.

Medtronic PLC’s stock price target has been raised by analysts, driven by the company’s turnaround potential and growth catalysts in its cardiac ablation business.

Boston Scientific Corp’s stock value has surged over 145% in the past three years, with analysts recommending investment in the company due to its strong performance and potential for future growth.

Abbott Laboratories has reported continued growth, with a moderate increase in its stock price and a substantial market capitalization, driven by its focus on health care products and services.

Sonova Holding AG’s stock price has seen a moderate 2.5% increase, but experts caution against reading too much into the trend due to the volatile market.

Sigma Healthcare Ltd has reported strong revenue growth in Q2 2025, with a cautiously optimistic market sentiment and potential for long-term expansion in the evolving pharmaceutical industry.

RBC Capital has raised its price target for Universal Health Services to $206, citing the company’s continued growth trajectory and strong position in the healthcare industry.

Elevance Health Inc. faces a setback in its lawsuit against the US government over Medicare star ratings, but the company has also expanded its food as medicine support to community health centers.